Newsletter - Recent Presentations of Hamlet Pharma
Hamlet Pharma has participated in a number of recent events, presenting highligts from the promising clinical studies and our future strategy. With this newsletter, we would like to invite you to see these presentations, using the links below.Hamlet Pharma's drug candidate Alpha1H has shown great promise as a cancer treatment in animal models and in clinical studies. We have chosen bladder cancer as the first clinical indication. Bladder cancers are extremely common and difficult to treat. The a lack of new therapies makes bladder cancer one of the most expensive cancer forms and the FDA